AU Patent

AU2013249307B2 — Compositions and methods for non-invasive imaging

Assigned to Merrimack Pharmaceuticals Inc · Expires 2017-11-09 · 9y expired

What this patent protects

The present invention relates to a novel composition useful in targeted diagnostic and/or therapy of a target site, such as cancerous tissue. The composition and methods disclosed herein find particular use in diagnosing and imaging cancerous tissue. The present invention provide…

USPTO Abstract

The present invention relates to a novel composition useful in targeted diagnostic and/or therapy of a target site, such as cancerous tissue. The composition and methods disclosed herein find particular use in diagnosing and imaging cancerous tissue. The present invention provides a new diagnostic tool for the utilization of positron emission tomography (PET) imaging technique.

Drugs covered by this patent

Patent Metadata

Patent number
AU2013249307B2
Jurisdiction
AU
Classification
—
Expires
2017-11-09
Drug substance claim
No
Drug product claim
No
Assignee
Merrimack Pharmaceuticals Inc
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.